Simple Summary Papillary thyroid carcinoma (PTC) represents 80–90% of all differentiated
thyroid carcinomas. PTC has a high rate of gene fusions and mutations, which can influence …

The dearth of potential of diagnostic and treatment methods hinders the fight against tumors.
The advances in nanotechnology are emerging, expressing countless latent applications …

Objectives To screen out the predictors of central cervical lymph node metastasis (CLNM) for
papillary thyroid carcinoma (PTC) and establish a prediction model to guide the operation of …

Background In clinical practice, thyroid tumor size plays a critical role in the staging of
thyroid malignancies and in the selection of nodules that should undergo ultrasound-guided …

Background Papillary thyroid carcinoma (PTC) is one of most prevalent malignant endocrine
neoplasms, and it is associated with a high frequency of BRAF gene mutations, which lead …

Introduction BRAF V600E and RAS mutations are the most common gene mutations in
papillary thyroid carcinoma (PTC) that may be correlated with its biological behavior. There …

Background Papillary thyroid microcarcinomas (PTMCs) have been attributed to the recent
increased incidence of thyroid cancer. Although indolent, a subset of PTMC could potentially …

Background: Thyroid cancer (TC) is a common endocrine malignancy that frequently
harbours the oncogenic V600E BRAF mutation. This mutation has received considerable …

Purpose: Aberrant DNA methylation plays a crucial role in the tumorigenesis of differentiated
thyroid cancer (DTC); nevertheless, the factors leading to the local and regional recurrence …

Papillary thyroid carcinoma (PTC) is the most common thyroid cancer, posing a growing
clinical challenge. PTC exhibits two age-related peaks, with established risk factors …